{"id":55879,"date":"2024-02-07T05:43:55","date_gmt":"2024-02-07T05:43:55","guid":{"rendered":"https:\/\/medsname.com\/brimolol-eye-drop\/"},"modified":"2026-04-30T10:24:43","modified_gmt":"2026-04-30T10:24:43","slug":"brimolol-eye-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/brimolol-eye-drop\/","title":{"rendered":"Brimolol o\u010dn\u00ed kapky"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Quick Answer \u2014 What is Brimolol Eye Drop?<\/h3>\n

Brimolol Eye Drop combines brimonidine 0.2% (alpha-2 agonist) with timolol 0.5% (beta-blocker) in one bottle for advanced glaucoma. Twice daily. Avoid in asthma, severe COPD, bradycardia, AV block, and children < 2 years.<\/p>\n<\/div>\n

Pro\u010d objedn\u00e1vat z MedsBase?<\/strong> Dod\u00e1v\u00e1no od v\u00fdrobce certifikovan\u00e9ho WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Doprava po cel\u00e9m sv\u011bt\u011b \u00b7 1 400+ ov\u011b\u0159en\u00fdch recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n

\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n

Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n

Brimolol Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 pokud nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me bez dal\u0161\u00edch n\u00e1klad\u016f. Podpo\u0159eno v\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdmi recenzemi z\u00e1kazn\u00edk\u016f.<\/p>\n

What is Brimolol Eye Drop?<\/h2>\n

Brimolol Eye Drop is a fixed-dose combination eye drop manufactured by Sun Pharma, containing brimonidine tartrate 0.2% and timolol maleate 0.5% in a 5 mL bottle. The two ingredients reduce aqueous humour production through complementary mechanisms \u2014 alpha-2 agonism and beta-adrenergic blockade \u2014 for additive ~25\u201328% IOP reduction in twice-daily dosing.<\/p>\n

Jak to funguje<\/h2>\n

Brimonidin<\/strong> aktivuje alfa-2 receptory v \u0159asnat\u00e9m epitelu, sni\u017euje cAMP a sekreci komorov\u00e9 vody, z\u00e1rove\u0148 zvy\u0161uje uveoskler\u00e1ln\u00ed odtok. Timolol<\/strong> blokuje beta-1\/beta-2 receptory ve stejn\u00e9m epitelu, d\u00e1le sni\u017euje produkci komorov\u00e9 vody. Kombinace je \u00fa\u010dinn\u011bj\u0161\u00ed ne\u017e monoterapie kteroukoli slo\u017ekou.<\/p>\n

D\u00e1vkov\u00e1n\u00ed<\/h2>\n

Jednu kapku do posti\u017een\u00e9ho oka (o\u010d\u00ed) dvakr\u00e1t denn\u011b, ide\u00e1ln\u011b v 12hodinov\u00fdch intervalech. Po\u010dkejte 5 minut, pokud pou\u017e\u00edv\u00e1te dal\u0161\u00ed o\u010dn\u00ed kapky. Po ka\u017ed\u00e9 kapce prove\u010fte punk\u010dn\u00ed okluzi na 1\u20132 minuty. Vyjm\u011bte kontaktn\u00ed \u010do\u010dky; znovu je nasa\u010fte a\u017e po 15 minut\u00e1ch.<\/p>\n

Trojit\u00e1 kontrola bezpe\u010dnosti.<\/strong> Slo\u017eka timololu kontraindikuje $brand u astmatu, t\u011b\u017ek\u00e9 CHOPN, sinusov\u00e9 bradykardie, AV blok\u00e1dy druh\u00e9ho\/t\u0159et\u00edho stupn\u011b, dekompenzovan\u00e9ho srde\u010dn\u00edho selh\u00e1n\u00ed. Slo\u017eka brimonidinu kontraindikuje $brand u d\u011bt\u00ed < 2 let (\u017eivot ohro\u017euj\u00edc\u00ed apnoe) a je relativn\u00ed kontraindikac\u00ed s inhibitory MAO.<\/div>\n

Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n

Lok\u00e1ln\u00ed:<\/strong> konjunktiv\u00e1ln\u00ed hyper\u00e9mie, alergick\u00e1 konjunktivitida (pozdn\u00ed n\u00e1stup, typick\u00e1 pro brimonidin), p\u00e1len\u00ed, rozmazan\u00e9 vid\u011bn\u00ed, o\u010dn\u00ed sv\u011bd\u011bn\u00ed.<\/p>\n

Syst\u00e9mov\u00e9:<\/strong> sucho v \u00fastech, \u00fanava, ospalost, hypotenze, bradykardie, bronchospazmus u reaktivn\u00edch d\u00fdchac\u00edch cest.<\/p>\n

Varov\u00e1n\u00ed a kontraindikace<\/h2>\n